These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 20808682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
    Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.
    Intern Med; 2007; 46(11):771-4. PubMed ID: 17541233
    [Abstract] [Full Text] [Related]

  • 3. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
    Takeuchi N, Arai T, Kitaichi M, Inoue Y.
    BMJ Case Rep; 2013 Sep 26; 2013():. PubMed ID: 24072826
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab).
    Otani N, Morishita Y, Oh I, Saito O, Takemoto F, Muto S, Kusano E.
    Intern Med; 2012 Sep 26; 51(11):1375-8. PubMed ID: 22687845
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H, Kotani S, Matsumura Y, Kondo T, Katsurada T, Haga H, Kadowaki N, Takaori-Kondo A.
    Intern Med; 2013 Sep 26; 52(13):1503-7. PubMed ID: 23812199
    [Abstract] [Full Text] [Related]

  • 11. Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody.
    Galeotti C, Boucheron A, Guillaume S, Koné-Paut I.
    Mol Cancer Ther; 2012 Aug 26; 11(8):1623-6. PubMed ID: 22638145
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sustained remission of severe Multicentric Castleman disease following multiagent chemotherapy and tocilizumab maintenance.
    Turcotte LM, Correll CK, Reed RC, Moertel CL.
    Pediatr Blood Cancer; 2014 Apr 26; 61(4):737-9. PubMed ID: 24019247
    [Abstract] [Full Text] [Related]

  • 14. A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus.
    Sumiyoshi R, Koga T, Furukawa K, Umeda M, Yamamoto K, Mori R, Kawakami A.
    Clin Immunol; 2021 Dec 26; 233():108887. PubMed ID: 34798240
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases.
    Nagao A, Nakazawa S, Hanabusa H.
    J Hematol Oncol; 2014 Jan 17; 7():10. PubMed ID: 24438824
    [Abstract] [Full Text] [Related]

  • 17. The Role of Interleukin-6 in Castleman Disease.
    Yoshizaki K, Murayama S, Ito H, Koga T.
    Hematol Oncol Clin North Am; 2018 Feb 17; 32(1):23-36. PubMed ID: 29157617
    [Abstract] [Full Text] [Related]

  • 18. [Effectiveness of humanized anti-interleukin-6 receptor antibody (tocilizumab) for Castleman's disease mainly with pulmonary involvement].
    Ohno N, Fujiyama S, Ooi M, Haraguchi K, Tokunaga M, Uozumi K, Tsubouchi H.
    Nihon Naika Gakkai Zasshi; 2007 May 10; 96(5):988-90. PubMed ID: 17564092
    [No Abstract] [Full Text] [Related]

  • 19. [Dyspnoea, cough and B symptoms in a 40-year-old woman].
    Wolfensberger A, Benz R, Russi EW, Tinguely M, Keller C, Gerber B.
    Internist (Berl); 2013 Aug 10; 54(8):1011-5. PubMed ID: 23836253
    [Abstract] [Full Text] [Related]

  • 20. Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease.
    Taniguchi K, Shimazaki C, Fujimoto Y, Shimura K, Uchiyama H, Matsumoto Y, Kuroda J, Horiike S, Taniwaki M.
    Int J Hematol; 2009 Jul 10; 90(1):99-102. PubMed ID: 19554396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.